Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
作者信息
Pedrazzani Corrado, Turri Giulia, Ostuzzi Giovanni, Barbui Corrado
机构信息
Department of Engineering for Innovation Medicine, Section of General and Hepatobiliary Surgery, University of Verona, Verona, Italy.
Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, Section of General and Hepatobiliary Surgery, University of Verona, Verona, Italy.
出版信息
Br J Surg. 2024 Aug 2;111(8). doi: 10.1093/bjs/znae209.
Abstract
摘要
相似文献
1
2
Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.作者对以下内容的回应：对《局部晚期直肠癌治疗的全新辅助治疗与标准新辅助治疗策略：随机临床试验的网状Meta分析》的评论
Br J Surg. 2024 Aug 2;111(8). doi: 10.1093/bjs/znae211.
3
Optimal choice of different neoadjuvant chemoradiotherapies for locally advanced rectal cancer: systematic review and network meta-analysis.局部晚期直肠癌不同新辅助放化疗的最佳选择：系统评价与网状Meta分析
Cancer Metastasis Rev. 2025 Jul 23;44(3):62. doi: 10.1007/s10555-025-10279-x.
4
Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis.局部晚期直肠癌新辅助放化疗时代的治疗选择：系统评价和网络荟萃分析。
JAMA Netw Open. 2024 Jun 3;7(6):e2414702. doi: 10.1001/jamanetworkopen.2024.14702.
5
Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.局部晚期直肠癌治疗中全新辅助治疗与标准新辅助治疗策略的比较：随机临床试验的网状Meta分析
Br J Surg. 2023 Sep 6;110(10):1316-1330. doi: 10.1093/bjs/znad177.
6
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials.局部晚期直肠癌的 FOLFIRINOX 或奥沙利铂为基础的双联方案诱导治疗，随后进行长程放化疗和手术：来自 II 期和 III 期试验的系统评价和汇总分析。
Cancer Treat Rev. 2024 Nov;130:102829. doi: 10.1016/j.ctrv.2024.102829. Epub 2024 Sep 16.
7
Network meta-analysis of RTCs for efficacy of neoadjuvant treatment in rectal cancer.直肠癌新辅助治疗疗效的随机对照试验的网络荟萃分析。
Eur J Surg Oncol. 2025 Apr 5;51(8):110019. doi: 10.1016/j.ejso.2025.110019.
8
Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trial.直肠癌患者的选择性新辅助治疗（SELREC）：一项欧洲随机对照、开放、多中心非劣效性试验的研究方案
BMJ Open. 2025 Jun 26;15(6):e092807. doi: 10.1136/bmjopen-2024-092807.
9
A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.一项比较II期和III期直肠癌新辅助治疗策略的随机对照试验的系统评价和网状Meta分析。
Crit Rev Oncol Hematol. 2023 Mar;183:103927. doi: 10.1016/j.critrevonc.2023.103927. Epub 2023 Jan 24.
10
Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R).一项关于循环肿瘤DNA指导的局部晚期直肠癌新辅助治疗策略的多中心随机对照试验（CINTS-R）的原理与设计
BMJ Open. 2025 Feb 2;15(1):e090765. doi: 10.1136/bmjopen-2024-090765.
本文引用的文献
1
Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.局部晚期直肠癌治疗中全新辅助治疗与标准新辅助治疗策略的比较：随机临床试验的网状Meta分析
Br J Surg. 2023 Sep 6;110(10):1316-1330. doi: 10.1093/bjs/znad177.
Zotero 插件